US$ 26.43
glp 1 drugs alzheimer's GLP-1 Microdosing, Brain Health & Prevention GLP-1 Drug Fails to Improve
Description
Reddys Laboratories, shared his thoughts: The launch of Colozo marks a significant milestone in our gastrointestinal portfolio in India and builds on our legacy of introducing novel, first-in-class therapies following the successful launch of BixiBat last year

You can now choose between GLP-1 pills or shots for weight loss

Glucagon-like peptide (GLP)-1 receptor agonists are the cornerstone in the treatment of hyperglycemia in many people suffering from type 2 diabetes (T2D)

However, there was no significant difference in adverse CVEs or all-cause mortality when compared with those taking SGLT2 inhibitors

Two major ongoing trials are likely to change that, with potentially big implications for clinical practice.

Methods A single-centre retrospective observational study
